Could anaesthesia, analgesia and sympathetic modulation affect neoplasic recurrence after surgery? A systematic review centred over the modulation of natural killer cells activity;L'anesthésie, l'analgésie et la modulation sympathique augmentent-elles l'incidence des récidives néoplasiques après chirurgie ? Une revue de la littérature centrée sur la modulation de l'activité des lymphocytes natural killer

Annales Francaises d'Anesthesie et de Reanimation

Volumn 28, Issue 9, 2009, Pages 751-768

  Forget, P ^a   De Kock, M ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Anaesthesia; Analgesia; Immunity; Natural Killer cells; Sympathetic system

Indexed keywords

ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; ANESTHETIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUPRENORPHINE; CLONIDINE; ETOMIDATE; FENTANYL; HALOTHANE; HYPNOTIC AGENT; ISOFLURANE; KETAMINE; METHADONE; METOPROLOL; MORPHINE; NADOLOL; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; ORCIPRENALINE; PETHIDINE; PLACEBO; PROPRANOLOL; PROSTAGLANDIN DERIVATIVE; REMIFENTANIL; SUFENTANIL; THIOPENTAL; TRAMADOL; UNINDEXED DRUG;

ADRENERGIC SYSTEM; ANALGESIC ACTIVITY; ANESTHESIA INDUCTION; ANTIINFLAMMATORY ACTIVITY; CELL ACTIVITY; CLINICAL TRIAL; DEPRESSION; DRUG RECEPTOR BINDING; HOST RESISTANCE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER METASTASIS; MEDLINE; METASTASIS; NATURAL KILLER CELL; NEUROMODULATION; NONHUMAN; PERIOPERATIVE PERIOD; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PERIOD; PROGNOSIS; REGIONAL ANESTHESIA; SHORT SURVEY; SYSTEMATIC REVIEW; TUMOR RECURRENCE;

ADRENERGIC AGENTS; ANALGESIA; ANALGESICS; ANESTHESIA; ANESTHETICS; ANIMALS; CELLS, CULTURED; CLINICAL TRIALS AS TOPIC; HUMANS; HYPNOTICS AND SEDATIVES; IMMUNOSUPPRESSION; KILLER CELLS, NATURAL; MICE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; NEUROIMMUNOMODULATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RATS; SYMPATHETIC NERVOUS SYSTEM;

EID: 70349287518     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2009.07.078     Document Type: Short Survey

References (200)

1. Shakhar G., and Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: Could they reduce recurrence rates in oncological patients?. Ann Surg Oncol 10 (2003) 972-992
2. Elenkov I.J., Wilders R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve - An integrative interface between two supersystems: The brain and the immune system. Pharmacol Rev 52 (2000) 592-638
3. Wrona D. Neural-immune interactions: An integrative view of the bidirectional relationship between the brain and immune systems. J Neuroimmunol 172 (2006) 38-58
4. Schaffer M., Beiter T., Becker H.D., and Hunt T.K. Neuropeptides: mediators of inflammation and tissue repair?. Arch Surg 133 (1998) 1107-1116
5. Zaugg M., Schulz C., Wacker I., and Schaub M.C. Sympatho-modulatory therapies in perioperative medicine. Br J Anaesth 93 (2004) 53-62
6. Ben-Eliyahu S., Page G.G., and Schleifer S.J. Stress, NK cells, and cancer: Still a promissory note. Brain Behav Immun 21 (2007) 881-887
7. Galley H.F., DiMatteo M.A., and Webster N.R. Immunomodulation by anaesthetic, sedative and analgesic agents: Does it matter?. Intensive Care Med 26 (2000) 267-274
8. Page G.G. Immunologic effects of opioids in the presence or absence of pain. J Pain Symptom Manage 29 S5 (2005) S25-31
9. Panerai A.E., and Sacerdote P. Beta-endorphin in the immune system: a role at last?. Immunol Today 18 (1997) 317-319
10. Docquier M.A., Lavand'homme P., Boulanger V., Collet V., and De Kock M. Questioning the cardiocirculatory effects of opioids under volatile anaesthesia. Br J Anaesth 93 (2004) 408-413
11. Page G.G., Blakelya W.P., and Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 90 (2001) 191-199
12. Curtis J.L., and Punturieri A. Enhancing antitumor immunity perioperatively: a matter of timing, cooperation, and specificity. Am J Respir Cell Mol Biol 28 (2003) 541-545
13. Liljefors M., Nilsson B., Hielm Skog A.L., Ragnhammar P., Mellstedt H., and Frödin J.E. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A. Int J Cancer 105 (2003) 717-723
14. Page G.G., McDonald J.S., and Ben-Eliyahu S. Pre-operative versus postoperative administration of morphine: impact on the neuroendocrine, behavioural, and metastatic-enhancing effects of surgery. Br J Anaesth 81 (1998) 216-223
15. Shavit Y., Lewis J.W., Terman G.W., Gale R.P., and Liebeskind J.C. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223 (1984) 188-190
16. Whiteside T.L., and Herberman R.B. Role of human natural killer cells in health and disease. Clin Diagn Lab Immunol 1 (1994) 125-133
17. Bernard C. Leçons sur les effets des substances toxiques et médicamenteuses (1857), Baillière, Paris 359-368 [488 p. Cours, Collège de France]
18. Snel J.J. Immunitat und narkose. Berlin Klin WSCHR 40 (1903) 212
19. Moudgil J.C. Effect of premedicants, intravenous anaesthetic agents and local anaesthetics on phagocytosis in vitro. Can Anaesth Soc J 28 (1981) 597-602
20. Coley W.B. Contribution to the knowledge of sarcoma. Ann Surg 14 (1891) 199-220
21. Buinauskas P., McDonald G.O., and Cole W.H. Role of operative stress on the resistance of the experimental animal to inoculated cancer cells. Ann Surg 148 (1958) 642-645
22. Brunner K.T., Mauel J., Cerottini J.C., and Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14 (1968) 181-196
23. Schlager S.I., Boyle M.D., Ohanian S.H., and Borsos T. Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement. Cancer Res 37 (1977) 1432-1437
24. Desborough J.P. The stress response to trauma and surgery. Br J Anaesth 85 (2000) 109-117
25. Shavit Y., Depaulis A., Martin F.C., Terman G.W., Pechnick R.N., Zane C.J., et al. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc Natl Acad Sci U S A 83 (1986) 7114-7117
26. Shapiro J., Jersky J., Katzav S., Feldman M., and Segal S. Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest 68 (1981) 678-685
27. Exadaktylos A.K., Buggy D.J., Moriarty D.C., Mascha E., and Sessler D.I. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis?. Anesthesiology 105 (2006) 660-664
28. Biki B., Mascha E., Moriarty D.C., Fitzpatrick J.M., Sessler D.I., and Buggy D.J. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 109 (2008) 180-187
29. Millan M.J. The induction of pain: an integrative review. Prog Neurobiol 57 (1999) 1-164
30. Viswanathan K., Daugherty C., and Dhabhar F.S. Stress as an endogenous adjuvant: augmentation of the immunization phase of cell-mediated immunity. Int Immunol 17 (2005) 1059-1069
31. Stefano G.B., and Kream R. Endogenous opiates, opioids, and immune function: Evolutionary brokerage of defensive behaviors. Semin Cancer Biol 18 (2008) 190-198
32. McCarthy L., Wetzel M., Sliker J.K., Eisenstein T.K., and Rogers T.J. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 62 (2001) 111-123
33. Gomez-Flores R., and Weber R.J. Inhibition of interleukin-2 production and downregulation of IL-2 and transferring receptors on rat splenic lymphocytes following PAG morphine administration: a role in natural killer and T cell suppression. J Interferon Cytokine Res 19 (1999) 625-630
34. Bruehl S., and Chung O.Y. Interactions between the cardiovascular and pain regulatory systems: an updated review of mechanisms and possible alterations in chronic pain. Neurosci Biobehav Rev 28 (2004) 395-414
35. Walker W., and Rotondo D. Prostaglandin E2 is a potent regulator of interleukin-12 and interleukin-18-induced natural killer cell interferon-gamma synthesis. Immunology 111 (2004) 298-305
36. Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth 78 (1997) 606-617
37. Peng Y.P., Qiu Y.H., Jiang J.L., and Wang J.J. Effect of catecholamines on IL-2 production and NK cytotoxicity of rats in vitro. Acta Pharmacol Sin 25 (2004) 1354-1360
38. Orange J.S., and Ballas Z.K. Natural killer cells in human health and disease. Clin Immunol 118 (2006) 1-10
39. Kirwan S.E., and Burshtyn D.N. Regulation of natural killer cell activity. Curr Opin Immunol 19 (2007) 46-54
40. Berzofsky J.A., and Terabe M. NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis. J Immunol 180 (2008) 3627-3635
41. Gaspani L., Bianchi M., Limiroli E., Panerai A.E., and Sacerdote P. The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats. J Neuroimmunol 129 (2002) 18-24
42. Whiteside T.L., and Herberman R.B. The role of natural killer cells in human disease. Clin Immunol Immunopathol 53 (1989) 1-23
43. Bar-Yosef S., Melamed R., Page G.G., Shakhar G., Shakhar K., and Ben-Eliyahu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 94 (2001) 1066-1073
44. Nelson C.L., Dykstra L.A., and Lysle D.T. Comparison of the time course of morphine's analgesic and immunologic effects. Anesth Analg 85 (1997) 620-626
45. Yeager M.P., Yu C.T., Campbell A.S., Moschella M., and Guyre P.M. Effect of morphine and beta-endorphin on human Fc receptor-dependent and natural killer cell functions. Clin Immunol Immunopathol 62 (1992) 336-343
46. Fuggetta M.P., Di Francesco P., Falchetti R., Cottarelli A., Rossi L., Tricario M., et al. Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells. J Exp Clin Cancer Res 24 (2005) 255-263
47. Condevaux F., Guichard J., Forichon A., Aujoulat M., and Descotes J. Compared effects of morphine and nickel chloride on NK cell activity in vitro in rats and monkeys. J Appl Toxicol 21 (2001) 431-434
48. Coussons-Read M.E., and Giese S. Acute morphine treatment alters cellular immune function in the lungs of healthy rats. Int Immunopharmacol 1 (2001) 1571-1581
49. Thomas P.T., Bhargava H.N., and House R.V. Immunomodulatory effects of in vitro exposure to morphine and its metabolites. Pharmacology 50 (1995) 51-62
50. Freier D.O., and Fuchs B.A. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity. J Pharmacol Exp Ther 270 (1994) 1127-1133
51. Carr D.J., Gerak L.R., and France C.P. Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice. J Pharmacol Exp Ther 269 (1994) 693-698
52. Carr D.J., Mayo S., Gebhardt B.M., and Porter J. Central alpha-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity. J Neuroimmunol 53 (1994) 53-63
53. Pacifici R., Patrini G., Venier I., Parolaro D., Zuccaro P., and Gori E. Effect of morphine and methadone acute treatment on immunological activity in mice: pharmacokinetic and pharmacodynamic correlates. J Pharmacol Exp Ther 269 (1994) 1112-1116
54. Kraut R.P., and Greenberg A.H. Effects of endogenous and exogenous opioids on splenic natural killer cell activity. Nat Immun Cell Growth Regul 5 (1986) 28-40
55. Bhargava H.N., House R.V., Thorat S.N., and Thomas P.T. Effects of naltrexone on morphine-induced tolerance and physical dependence and changes in cellular immune function in mice. Brain Res 690 (1995) 121-126
56. Carpenter G.W., and Carr D.J. Pretreatment with beta-funaltrexamine blocks morphine-mediated suppression of CTL activity in alloimmunized mice. Immunopharmacology 29 (1995) 129-140
57. Carr D.J., and Carpendter G.W. Morphine-induced suppression of cytotoxic T lymphocyte activity in alloimmunized mice is not mediated through a naltrindole-sensitive delta opioids receptor. Neuroimmunomodulation 2 (1995) 44-53
58. Tsai Y.C., Won S.J., and Lin M.T. Effects of morphine on immune response in rats with sciatic constriction injury. Pain 88 (2000) 155-160
59. Gomez-Flores R., and Weber R.J. Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray. Immunopharmacology 48 (2000) 145-156
60. Fecho K., and Lysle D.T. Phenotypic analysis of splenocyte subsets following acute morphine treatment in the rat. Cell Immunol 195 (1999) 137-146
61. Fecho K., Maslonek K.A., Dykstra L.A., and Lysle D.T. Acetylcholinesterase monoclonal antibody-induced sympathectomy: effects on immune status and acute morphine-induced immunomodulation. Brain Behav Immun 11 (1997) 167-184
62. Fecho K., Maslonek K.A., Dykstra L.A., and Lysle D.T. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. J Pharmacol Exp Ther 277 (1996) 633-645
63. Fecho K., Maslonek K.A., Dykstra L.A., and Lysle D.T. Assessment of the involvement of central nervous system and peripheral opioids receptors in the immunomodulatory effects of acute morphine treatment in rats. J Pharmacol Exp Ther 276 (1996) 626-636
64. Coussons-Read M.E., Dykstra L.A., and Lysle D.T. Pavlovian conditioning of morphine-induced alterations of immune status: evidence for opioids receptor involvement. J Neuroimmunol 55 (1994) 135-142
65. Bhargava H.N., Thomas P.T., Thorat S., and House R.V. Effects of morphine tolerance and abstinence on cellular immune function. Brain Res 642 (1994) 1-10
66. Fecho K., Maslonek K.A., Dykstra L.A., and Lysle D.T. Alterations of immune status induced by the sympathetic nervous system: immunomodulatory effects of DMPP alone and in combination with morphine. Brain Behav Immun 7 (1993) 253-270
67. Lysle D.T., Coussons M.E., Watts V.J., Bennett E.H., and Dykstra L.A. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J Pharmacol Exp Ther 265 (1993) 1071-1078
68. Carr D.J., Gebhardt B.M., and Paul D. Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J Pharmacol Exp Ther 264 (1993) 1179-1186
69. Bayer B.M., Daussin S., Hernandez M., and Irvin L. Morphine inhibition of lymphocyte activity is mediated by an opioids dependent mechanism. Neuropharmacology 29 (1990) 369-374
70. Yirmiya R., Shavit Y., Ben-Eliyahu S., Martin F.C., Weiner H., and Liebeskind J.C. Natural killer cell activity in vasopressin-deficient rats (Brattleboro strain). Brain Res 479 (1989) 16-22
71. Weber R.J., and Pert A. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245 (1989) 188-190
72. Page G.G., Ben-Eliyahu S., and Liebeskind J.C. The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav Immun 8 (1994) 241-250
73. Page G.G., Ben-Eliyahu S., Yirmiya R., and Liebeskind J.C. Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain 54 (1993) 21-28
74. Gaveriaux-Ruff C., Matthes H.W., Peluso J., and Kieffer B.L. Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene. Proc Natl Acad Sci U S A 95 11 (1998) 6326-6330
75. Saurer T.B., Ijames S.G., Lysle D.T., and Neuropeptide. Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. J Neuroimmunol 177 (2006) 18-26
76. Saurer T.B., Carrigan K.A., Ijames S.G., and Lysle D.T. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell. J Neuroimmunol 173 (2006) 3-11
77. Saurer T.B., Carrigan K.A., Ijames S.G., and Lysle D.T. Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT. J Neuroimmunol 148 (2004) 54-62
78. Liang-Suo J., Gomez-Florez R., and Weber R.J. Immunosuppression induced by central action of morphine is not blocked by mifepristone (RU 486). Life Sci 18 (2002) 2595-2602
79. Shavit Y., Terman G.W., Lewis J.W., Zane C.J., Gale R.P., and Liebeskind J.C. Effects of footshock stress and morphine on natural killer lymphocytes in rats: studies of tolerance and cross-tolerance. Brain Res 372 (1986) 382-385
80. Shavit Y., Martin F.C., Yirmiya R., Ben-Eliyahu S., Terman G.W., Weiner H., et al. Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity. Brain Behav Immun 1 (1987) 318-328
81. West J.P., Dykstra L.A., and Lysle D.T. Differential tolerance to morphine's immunomodulatory effects following continuous administration. Drug Alcohol Depend 53 (1998) 31-38
82. West J.P., Lysle D.T., and Dykstra L.A. Tolerance development to morphine-induced alterations of immune status. Drug Alcohol Depend 46 (1997) 147-157
83. Van der Laan J.W., Timmerman H., and Van Loveren H. Comparison of the in vivo effects of morphine and methadone on natural killer cell activity in spleen, peritoneal cavity in spleen, peritoneal cavity, and lungs in rats. Int J Immunopharmacol 18 (1996) 401-407
84. Martin J.T., Nehlsen-Cannarella S.L., Gugelchuk G.M., and Fagoaga O.R. Morphine during pregnancy in the rat. Studies of cellular immunity in cross-fostered offspring. Adv Exp Med Biol 437 (1998) 149-157
85. Shavit Y., Cohen E., Gagin R., Avitsur R., Pollak Y., Chaikin G., et al. Effects of prenatal morphine exposure on NK cytotoxicity and responsiveness to LPS in rats. Pharmacol Biochem Behav 59 (1998) 835-841
86. Franchi S., Panerai A.E., and Sacerdote P. Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment. Brain Behav Immun 21 (2007) 767-774
87. Colacchio T.A., Yeager M.P., and Hildebrandt L.W. Perioperative immunomodulation in cancer surgery. Am J Surg 167 (1994) 171-179
88. Mellon R.D., and Bayer B.M. Reversal of acute effects of high dose morphine on lymphocyte activity by chlorisondamine. Drug Alcohol Depend 62 (2001) 141-147
89. Carrigan K.A., and Lysle D.T. Morphine-6 beta-glucuronide induces potent immunomodulation. Int Immunopharmacol 1 (2001) 821-831
90. Carr D.J., and France C.P. Immune alterations in morphine-treated rhesus monkeys. J Pharmacol Exp Ther 267 (1993) 9-15
91. Yeager M.P., Colacchio T.A., Yu C.T., Hildebrandt L., Howell A.L., Weiss J., et al. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 83 (1995) 500-508
92. Provinciali M., Di Stefano G., Stronati S., Raffaeli W., Pari G., and Fabris N. Role of prolactin in the modulation of NK and LAK cell activity after short- or long-term morphine administration in neoplasic patients. Int J Immunopharmacol 18 (1996) 577-586
93. Provinciali M., Di Stefano G., Raffaeli W., Pari G., Desiderio F., and Fabris N. Evaluation of NK and LAK cell activities in neoplastic patients during treatment with morphine. Int J Neurosci 59 (1991) 127-133
94. Yokota T., Uehara K., and Nomoto Y. Addition of noradrenalin to intrathecal morphine augments the postoperative suppression of natural killer activity. J Anesth 18 (2004) 190-195
95. Yokota T., Uehara K., and Nomoto Y. Intrathecal morphine suppresses NK cell activity following abdominal surgery. Can J Anaesth 47 (2000) 303-308
96. Zhang Y., Du L., Wu G., Cao X., and Electro-acupuncture. (EA) induced attenuation of immunosuppression appearing after epidural or intrathecal injection of morphine in patients and rats. Acupunct Electrother Res 21 (1996) 177-186
97. Sacerdote P., Bianchi M., Gaspani L., Manfredi B., Maucione A., Terno G., et al. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg 90 (2000) 1411-1414
98. Beilin B., Shavit Y., Trabekin E., Mordashev B., Mayburd E., Zeidel A., et al. The effects of postoperative pain management in immune response to surgery. Anesth Analg 97 (2003) 822-827
99. Momeni M., Crucitti M., and De Kock M. Patient-controlled analgesia in the management of postoperative pain. Drugs 66 (2006) 2321-2337
100. Shavit Y., Ben-Eliyahu S., Zeidel A., and Beilin B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Neuroimmunomodulation 11 (2004) 255-260
101. Forget P, Collet V, Lavand'homme P, De Kock M. Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages. Eur J Anaesthesiol 2009 [Epub ahead of print].
102. Beilin B., Shavit Y., Cohn S., and Kedar E. Narcotic-induced suppression of natural killer cell activity in ventilated and nonventilated rats. Clin Immunol Immunopathol 64 (1992) 173-176
103. House R.V., Thomas P.T., and Bhargava H.N. In vitro evaluation of fentanyl and meperidine for immunomodulatory activity. Immunol Lett 46 (1995) 117-124
104. Martucci C., Panerai A.E., and Sacerdote P. Chronic fentanyl or buprenorphine infusion in the mouse; similar analgesic profile but different effects on immune responses. Pain 110 (2004) 385-392
105. Jacobs R., Karst M., Scheinichen D., Bevilacqua C., Schneider U., Haine J., et al. Effects of fentanyl on cellular immune functions in man. Int J Immunopharmacol 21 (1999) 445-454
106. Yeager M.P., Procopio M.A., DeLeo J.A., Arruda J.L., Hildebrandt L., and Howell A.L. Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16(+) lymphocytes in humans. Anesth Analg 94 (2002) 94-99
107. Beilin B., Shavit Y., Hart J., Mordashov B., Cohn S., Notti I., et al. Effects of anaesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg 82 (1996) 492-497
108. Sacerdote P., Gaspani L., Rossoni G., Panerai A.E., and Bianchi M. Effect of the opioid remifentanil on cellular immune response in the rat. Int Immunopharmacol 1 (2001) 713-719
109. Cronin A.J., Aucutt-Walter N.M., Budinetz T., Bonafide C.P., DiVittore N.A., Gordin V., et al. Low-dose remifentanil infuction does not impair natural killer cell function in healthy volunteers. Br J Anaesth 91 (2003) 805-809
110. Beilin B., Martin F.C., Shavit Y., Gale R.P., and Liebeskind J.C. Suppression of natural killer cell activity by high-dose narcotic anesthesia in rats. Brain Behav Immun 3 (1989) 129-137
111. Akural E.I., Salomaki T.E., Bloigu A.H., Ryhanen P., Tekay A.H., Alahuhta S.M., et al. The effects of pre-emptive epidural sufentanil on human immune function. Acta Anaesthesiol Scand 45 6 (2004) 750-755
112. Molitor T.W., Murtaugh M.P., Click R.E., Gekker G., Chao C., and Peterson P.K. Functional alterations of swine peripheral blood mononuclear cells by methadone. J Leukoc Biol 51 (1992) 124-128
113. Ochshorn M., Novick D.M., and Kreek M.J. In vitro studies of the effect of methadone on natural killer cell activity. Isr J Med Sci 26 (1990) 421-425
114. Thomas P.T., House R.V., and Bhargava H.N. Direct cellular immunomodulation produced by diacetylmorphine (heroin) or methadone. Gen Pharmacol 26 (1995) 123-130
115. Novick D.M., Ochshorn M., Ghali V., Croxson T.S., Mercer W.D., Chiorazzi N., et al. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J Pharmacol Exp Ther 250 (1989) 606-610
116. Klimas N.G., Blaney N.T., Morgan R.O., Chitwood D., Milles K., Lee H., et al. Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone. Am J Med 90 (1991) 163-170
117. Carrigan K.A., Saurer T.B., Ijames S.G., and Lysle D.T. Buprenorphine produces naltrexone reversible alterations of immune status. Int Immunopharmacol 4 (2004) 419-428
118. Sacerdote P., Bianchi M., Gaspani L., and Panerai A.E. Effects of tramadol and its enantiomers on Concavalin-A induced-proliferation and NK activity of mouse splenocytes: involvement of serotonin. Int J Immunopharmacol 21 (1999) 727-734
119. Tsai Y.C., and Won S.J. Effects of tramadol on T lymphocyte proliferation and natural killer cell activity in rats with sciatic constriction injury. Pain 92 (2001) 63-69
120. De Kock M. La kétamine en anesthésie pédiatrique : utile, futile ou ... ?. Ann Fr Anesth Reanim 26 6 (2007) 524-528
121. Melamed R., Bar-Yosef S., Shakhar G., Shakhar K., and Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg 97 (2003) 1331-1339
122. Katzav S., Shapiro J., Segal S., and Feldman M. General anesthesia during excision of a mouse tumor accelerates postsurgical growth of metastases by suppression of natural killer cell activity. Isr J Med Sci 22 (1986) 339-345
123. Markovic S.N., and Murasko D.M. Anesthesia inhibits poly I:C induced stimulation of natural killer cell cytotoxicity in mice. Clin Immunol Immunopathol 56 (1990) 202-209
124. Bentley M.W., Stas J.M., Johnson J.M., Viet B.C., and Garett N. Effects of preincisional ketamine treatment in natural killer cell activity and postoperative pain management after oral maxillofacial surgery. AANA J 73 (2005) 427-436
125. Ben-Eliyahu S., Shakhar G., Rosenne R., Levinson Y., and Beilin B. Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis: a role for adrenergic mechanisms. Anesthesiology 91 (1999) 732-740
126. Procopio M.A., Rassias A.J., Deleo J.A., Pahl J., Hildebrandt L., and Yeager M.P. The in vivo effects of general and epidural anesthesia on human immune function. Anesth Analg 93 (2001) 460-465
127. Lee Y.S., Seo J.S., Chung H.T., Cho K.J., and Jan J.J. Lung adenoma development and NK activity in mice treated with multiple carcinogens. J Korean Med Sci 7 (1992) 1-5
128. Spinardi A.L., Kaneno R., Rodrigues M.A., Salvadori D.M., Rocha N.S., Barbisan L.F., et al. Natural killer activity in a medium-term multi-organ bioassay for carcinogenesis. Jpn J Cancer Res 90 (1999) 101-107
129. Stevenson G.W., Hall S., Rudnick S.J., Alvord G., Rossio J., Urba W., et al. Halothane anesthesia decreases human monocyte hydrogen peroxide generation. Protection of monocytes by activation with gamma interferon. Immunopharmacol Immunotoxicol 9 (1987) 489-510
130. Woods G.M., and Griffiths D.M. Reversible inhibition of natural killer cell activity by volatile anaesthetic agents in vitro. Br J Anaesth 58 (1986) 535-539
131. Markovic S.N., Knight P.R., and Murarko D.M. Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane. Anesthesiology 78 (1993) 700-706
132. Griffith C.D., and Kamath M.B. Effect of halothane and nitrous oxide anaesthesia on natural killer lymphocytes from patients with benign and malignant breast disease. Br J Anaesth 58 (1986) 540-543
133. Tonnesen E., Huttel M.S., and Christensen N.J. Natural killer cell activity in patients undergoing minor gynaecological surgery. Eur J Anaesthesiol 4 (1987) 112-125
134. Hellstrand K., and Hermodsson S. An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. Int Arch Allergy Appl Immunol 89 (1989) 334-341
135. Melamed R., Rosenne E., Shakhar K., Schwartz Y., Abudarham N., and Ben-Eliyahu S. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun 19 (2005) 114-126
136. Shakhar G., and Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol 160 (1998) 3251-3258
137. Hong-Fen L., Waisman T., Maimon Y., Shakhar K., Rosenne E., and Ben-Eliyahu S. The effects of a Chinese herb formula, anti-cancer number one (ACNO), on NK cell activity and tumor metastasis in rats. Int Immunopharmacol 1 (2001) 1947-1956
138. Shakhar K., Shakhar G., Rosenne E., and Ben-Eliyahu S. Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity. Br J Cancer 83 (2000) 1630-1636
139. Page G.G., and Ben-Eliyahu S. Natural killer cell activity and resistance to tumor metastasis in prepubescent rats: deficient baselines, but invulnerability to stress and beta-adrenergic stimulation. Neuroimmunomodulation 7 (2000) 160-168
140. Nomoto Y., Karasawa S., and Uehara K. Effects of hydrocortisone and adrenaline on natural killer cell activity. Br J Anaesth 73 (1994) 318-321
141. Nomoto Y., Jhonokosi H., and Karasawa S. Natural killer cell activity and lymphocyte subpopulations during dobutamine infusion in man. Br J Anaesth 71 (1993) 218-221
142. Tonnesen E., Christensen N.J., and Brinklov M.M. Natural killer cell activity during cortisol and adrenaline infusion in healthy volunteers. Eur J Clin Invest 17 (1987) 497-503
143. Nelson C.J., and Lysle D.T. Severity, time, and beta-adrenergic receptor involvement in surgery-induced immune alterations. J Surg Res 80 (1998) 115-122
144. Jiang X.H., Guo S.Y., Xu S., Yin Q.Z., Ohshita Y., Naitoh M., et al. Sympathetic nervous system mediates cold stress-induced suppression of natural killer cytotoxicity in rats. Neurosci Lett 357 (2004) 1-4
145. Luecken L.J., and Lysle D.T. Evidence for the involvement of beta-adrenergic receptors in conditioned immunomodulation. J Neuroimmunol 38 (1992) 209-219
146. Klokker M., Secher N.H., Madsen P., Pedersen M., and Pedersen B.K. Adrenergic beta 1- and 1 + 2-receptor blockade suppress the natural killer cell response to head-up tilt in humans. J Appl Physiol 83 (1997) 1492-1498
147. Wu W.J., and Pruett S.B. Suppression of splenic natural killer cell activity in a mouse model for binge drinking. II. Role of the neuroendocrine system. J Pharmacol Exp Ther 278 (1996) 1331-1339
148. Benschop R.J., Jacobs R., Sommer B., Schürmeyer T.H., Raab J.R., Schmidt R.E., et al. Modulation of the immunologic response to acute stress in humans by beta-blockade or benzodiazepines. FASEB J 10 (1996) 517-524
149. Bachen E.A., Manuck S.B., Cohen S., Muldoon M.F., Raible R., Herbert T.B., et al. Adrenergic blockade ameliorates cellular immune responses to mental stress in humans. Psychosom Med 57 (1995) 366-372
150. West J.P., Dykstra L.A., and Lysle D.T. Immunomodulatory effects of morphine withdrawal in the rat are time dependent and reversible by clonidine. Psychopharmacology 146 (1999) 320-327
151. Fiserova A., Starec M., Kuldova M., Kovaru H., Pav M., Vannucci L., et al. Effects of D2-dopamine and alpha-adrenoceptor antagonists in stress induced changes on immune responsiveness of mice. J Neuroimmunol 130 (2002) 55-65
152. Yakar I., Melamed R., Shakhar G., Rosenne E., Abudarham N., Page G.G., et al. Prostaglandin E(2) suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Ann Surg Oncol 10 (2003) 469-479
153. Matveeva V.A. Prostaglandin E(2) release by human and Syrian hamster tumor cells and their sensitivity to cytostatic activity of natural killers. Bull Exp Biol Med 131 (2001) 126-128
154. Joshi P.C., Zhou X., Cuchens M., and Jones Q. Prostaglandin E2 suppressed IL-15-mediated human NK cell function through down-regulation of common gamma-chain. J Immunol 166 (2001) 885-891
155. Ribeiro-Dias F., Marzagão Barbuto J.A., Tsujita M., and Jancar S. Discrimination between NK and LAK cytotoxic activities of murine spleen cells by MTT assay: differential inhibition by PGE(2) and EDTA. J Immunol Methods 241 (2000) 121-129
156. Kim C.D., Sung M.W., Lee S.J., Heo D.S., Yoon S.J., and Kim K.H. The effect of prostaglandin and its inhibitor on antibody-dependent cellular cytotoxicity against human squamous cell carcinoma of head and neck. Anticancer Res 19 (1999) 455-459
157. Klimberg V.S., Kornbluth J., Cao Y., Dang A., Blossom S., and Schaeffer R.F. Glutamine suppresses PGE2 synthesis and breast cancer growth. J Surg Res 63 (1996) 293-297
158. Okuno K., Jinnai H., Lee Y.S., Nakamura K., Hirohata T., and Shigeoka H.I.M. A high level of prostaglandin E2 (PGE2) in the portal vein suppresses liver-associated immunity and promotes liver metastases. Surg Today 25 (1995) 954-958
159. Baxevanis C.N., Reclos G.J., Gritzapis A.D., Dedousis G.V., Missitzis I., and Papamichail M. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer 72 (1993) 491-501
160. Malygin A.M., Meri S., and Timonen T. Regulation of natural killer cell activity by transforming growth factor-beta and prostaglandin E2. Scand J Immunol 37 (1993) 71-76
161. Vaillier D., Daculsi R., Gualde N., and Bezian J.H. Effect of LTB4 on the inhibition of natural cytotoxic activity by PGE2. Cell Immunol 139 (1992) 248-258
162. Waymack J.P., Flescher E., Venkatraman J., Fernandes G., Guzman R.F., Yurt R.W., et al. Effect of prostaglandin E in multiple experimental models. VIII. Effect on host response to metastatic tumor. J Surg Oncol 48 (1991) 239-245
163. Weir M.R., Li X.W., Gomolka D., Peppler R., O'Bryan-Tear C.G., and Moran M.A. The immunosuppressive properties of enisoprost and a 5-lipoxygenase inhibitor (SC-45662). Transplantation 52 (1991) 1053-1057
164. Bloom E.T., and Babbitt J.T. Prostaglandin E2, monocyte adherence and interleukin-1 in the regulation of human natural killer cell activity by monocytes. Nat Immun Cell Growth Regul 9 (1990) 36-48
165. Garcia-Peñarrubia P., Bankhurst A.D., and Koster F.T. Prostaglandins from human T suppressor/cytotoxic cells modulate natural killer antibacterial activity. J Exp Med 170 (1989) 601-606
166. Voiculescu C.L., Rosu L., and Rogoz S. Modulation of mouse spleen natural killer (NK) cell activity by beta-interferon, interleukin-1, and prostaglandins. Lymphology 21 (1988) 144-151
167. Garaci E., Mastino A., Jezzi T., Riccardi C., and Favalli C. Effect of in vivo administration of prostaglandins and interferon on natural killer activity and on B-16 melanoma growth in mice. Cell Immunol 106 (1987) 43-52
168. Fulton A.M. Interactions of natural effector cells and prostaglandins in the control of metastasis. J Natl Cancer Inst 78 (1987) 735-741
169. Lala P.K., Parhar R.S., and Singh P. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis. Cell Immunol 99 (1986) 108-118
170. Gatti G., Cavallo R., Sartori M.L., Marinone C., and Angeli A. Cortisol at physiological concentrations and prostaglandin E2 are additive inhibitors of human natural killer cell activity. Immunopharmacology 11 (1986) 119-128
171. Fulton A.M., and Heppner G.H. Relationships of prostaglandin E and natural killer sensitivity to metastatic potential in murine mammary adenocarcinomas. Cancer Res 45 (1985) 4779-4784
172. Deichman G., Dyakova N., Kashkina L., Matveeva V., and Uvarova E. The fingerprints of the host innate immunity on the cells of primary virus-induced tumors. Immunol Lett 75 (2001) 209-214
173. Fulton A.M. Inhibition of experimental metastasis with indomethacin: role of macrophages and natural killer cells. Prostaglandins 35 (1988) 413-425
174. Tanaka K., Tanaka H., Kanemoto Y., and Tsuboi I. The effects of nonsteroidal anti-inflammatory drugs on immune functions of human peripheral blood mononuclear cells. Immunopharmacology 40 (1998) 209-217
175. Rioux N., and Castonguay A. Recovery from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced immunosuppression in A/J mice by treatment with nonsteroidal anti-inflammatory drugs. J Natl Cancer Inst 89 (1997) 874-880
176. Knapp D.W., Richardson R.C., Chan T.C., Bottoms G.D., Widmer W.R., DeNicola D.B., et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 8 (1994) 273-278
177. Stanojević-Bakić N., Vucković-Dekić L., Radomirović S., Juranić Z., and Jovanović N. The influence of surgery and anesthesia on lymphocyte functions in breast cancer patients: in vitro effects of indomethacin. Neoplasma 46 (1999) 54-60
178. Rhind S.G., Gannon G.A., Suzui M., Shephard R.J., and Shek P.N. Indomethacin inhibits circulating PGE2 and reverses postexercise suppression of natural killer cell activity. Am J Physiol 276 (1999) R1496-R1505
179. Krog J., Hokland M., Ahlburg P., Parner E., and Tonnesen E. Lipid solubility- and concentration-dependent attenuation of in vitro natural killer cell cytotoxicity by local anesthetics. Acta Anaesthesiol Scand 46 (2002) 875-881
180. Huwyler T., Hirt A., Felix D., and Morell A. Effect of cations and cation channel blockers on human natural killer cells. Int J Immunopharmacol 7 (1985) 573-576
181. Takagi S., Kitagawa S., Oshimi K., Takaku F., and Miura Y. Effect of local anaesthetics on human natural killer cell activity. Clin Exp Immunol 53 (1983) 477-481
182. Renzi P.M., and Ginns L.C. Effect of lidocaine on natural killer activity: rapid inhibition of lysis. Immunopharmacol Immunotoxicol 12 (1990) 417-437
183. Yokoyama M., Itano Y., Mizobuchi S., Nakatsuka H., Kaku R., Takashima T., et al. The effects of epidural block on the distribution of lymphocyte subsets and natural-killer cell activity in patients with and without pain. Anesth Analg 92 (2001) 463-469
184. Klokker M., Kiaer M., Secher N.H., Hanel B., Worm L., Kappel M., et al. Natural killer cell response to exercise in humans: effect of hypoxia and epidural anesthesia. J Appl Physiol 78 (1995) 709-716
185. Koltun W.A., Bloomer M.M., Tilberg A.F., Seaton J.F., Ilahi O., Rung G., et al. Awake epidural anesthesia is associated with improved natural killer cell cytotoxicity and a reduced stress response. Am J Surg 171 (1996) 68-72
186. Tonnesen E., and Wahlgreen C. Influence of extradural and general anaesthesia on natural killer cell activity and lymphocyte subpopulations in patients undergoing hysterectomy. Br J Anaesth 60 (1988) 500-507
187. Salo M., and Nissila M. Cell-mediated and humoral immune responses to total hip replacement under spinal or general anaesthesia. Acta Anaesthesiol Scand 34 (1990) 241-248
188. Ryhänen P., Jouppila R., Lanning M., Jouppila P., Hollmén A., and Kouvalainen K. Natural killer cell activity after elective cesarean section under general and epidural anesthesia in healthy parturients and their newborns. Gynecol Obstet Invest 19 (1985) 139-142
189. Gasparoni A., Ciardelli L., De Amici D., Castellazzi A.M., Autelli M., Bottino R., et al. Effect of general and epidural anaesthesia on thyroid hormones and immunity in neonates. Paediatr Anaesth 12 (2002) 59-64
190. De Amici D., Gasparoni A., Chirico G., Ceriana P., Bartoli A., Ramajoli I., et al. Natural killer cell activity and delivery: possible influence of cortisol and anesthetic agents. A study on newborn cord blood. Biol Neonate 76 (1999) 348-354
191. Bray R., Abrams S., and Brahmi Z. Studies on the mechanism of human natural killer cell-mediated cytolysis. I. Modulation by dexamethasone and arachidonic acid. Cell Immunol 78 (1983) 100-113
192. Cox W.I., Holbrook N.J., and Friedman H. Mechanism of glucocorticoid action on murine natural killer cell activity. J Natl Cancer Inst 71 (1983) 973-981
193. Piccolella E., Lombardi G., Vismara D., Del Gallo F., Colizzi V., Dolei V., et al. Effects of dexamethasone on human natural killer cell cytotoxicity, interferon production, and interleukin-2 receptor expression induced by microbial antigens. Infect Immun 51 (1986) 712-714
194. Imir T., Sibbi W., and Bankhurst A. The relative resistance of prostaglandins and glucocorticoids. Prostaglandins Leukot Med 28 (1987) 111-118
195. O'Brien M.A., and Duffus W.P. The effects of dexamethasone, bethamethasone, flunixin and phenylbutazone on bovine natural-killer cytotoxicity. J Vet Pharmacol Ther 13 (1990) 292-297
196. Hsueh C.M., Rogers C., Hiramoto R.N., and Ghanta V.K. Effect of dexamethasone on conditioned enhancement of natural killer cell activity. Neuroimmunomodulation 1 (1994) 370-376
197. Martin-Kleiner I., and Gabrilovac J. Pretreatment of human peripheral blood lymphocytes with interleukin-2 on dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay. Immunopharmacol Immunotoxicol 18 (1996) 37-57
198. Anderson B.H., Watson D.L., and Colditz I.G. The effect of dexamethasone on some immunological parameters in cattle. Vet Res Commun 23 (1999) 399-413
199. Badner G., Ho A., Kreek M.S., and Kreek M.J. Effect of endogenous cortisol levels on natural killer cell activity in healthy humans. Brain Behav Immun 12 (1998) 285-296
200. Benschop R.J., Nieuwenhuis E.E., Tromp E.A., Godaert G.L., Ballieux R.E., and van Doornen L.J. Effects of beta-adrenergic blockade on immunologic and cardiovascular changes induced by mental stress. Circulation 89 (1994) 762-769